Results 201 to 210 of about 26,607 (237)
Some of the next articles are maybe not open access.
Acute promyelocytic leukemia and pregnancy
European Journal of Haematology, 2000Abstract: In acute promyelocytic leukemia (APL), the use of all‐trans‐retinoic acid (ATRA) as a differentiating agent induces complete remission in a high percentage of patients. In pregnancy, however, this drug bears the risk of severe teratogenicity to the child. We report the case of a 23‐yr‐old woman at 21 weeks' gestation suffering from APL.
A A, Giagounidis +8 more
openaire +2 more sources
History of Acute Promyelocytic Leukemia
2017Within a 60-year time span, the most severe acute leukemia—termed acute promyelocytic leukemia (APL) by the Norwegian author Leif Hillestad—was identified, characterized, and cured. The determination of a precise molecular definition of the genetic defect and the emergence of an antidogmatic paradigm have made the history of APL a model for the ...
openaire +2 more sources
Best Practice & Research Clinical Haematology, 2014
Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in ...
openaire +1 more source
Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in ...
openaire +1 more source
Treatment of Acute Promyelocytic Leukemia
New England Journal of Medicine, 2013Yuji, Miura +2 more
openaire +3 more sources
Management of acute promyelocytic leukemia
European Journal of Haematology, 1993openaire +2 more sources
Acute promyelocytic leukemia, arsenic, and PML bodies
Journal of Cell Biology, 2012Hugues de The +2 more
exaly
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
New England Journal of Medicine, 1998Steven L Soignet +2 more
exaly

